Cargando…
Challenges and exploration for immunotherapies targeting cold colorectal cancer
In recent years, immune checkpoint inhibitors (ICIs) have made significant breakthroughs in the treatment of various tumors, greatly improving clinical efficacy. As the fifth most common antitumor treatment strategy for patients with solid tumors after surgery, chemotherapy, radiotherapy and targete...
Autores principales: | Li, Dan-Dan, Tang, Yuan-Ling, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850757/ https://www.ncbi.nlm.nih.gov/pubmed/36684057 http://dx.doi.org/10.4251/wjgo.v15.i1.55 |
Ejemplares similares
-
Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023) -
Challenges to addressing the unmet medical needs for immunotherapy targeting cold colorectal cancer
por: Jeong, Keun-Yeong
Publicado: (2023) -
Exploring immunotherapy in colorectal cancer
por: Weng, Junyong, et al.
Publicado: (2022) -
“Cold” colorectal cancer faces a bottleneck in immunotherapy
por: Liu, Jia-Liang, et al.
Publicado: (2023) -
Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
por: Tang, Yuan-Ling, et al.
Publicado: (2023)